AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial.

Name: Αlpha¹ Rigor Record — AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial.
Item: AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial.
Rating: 59
Author: Αlpha¹

Woznitza N, Smith L, Rawlinson J, Au-Yong I, George B, Djearaman MG, Nair A, Lee RW, Navani N, Ndwandwe S, Clarke CS, Creeden A, Newsome J, Das I, Abaokporo S, Tucker R, Hathorn J, Baldwin DR

Paper source

Read full text (PMC)

Embed this Rigor badge

Αlpha¹ Rigor Review — 1.25★ (Critical), 0 critical, 2 high issues for “AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial.”

Links back to this Rigor Record.

Αlpha¹ Editorial

This rigor review was examined and confirmed by Αlpha¹ Editorial · August 15, 2026

Αlpha¹ Rigor Review

Rigor Reviewed

1.25 / 5

Critical — serious problems across many checks

Interventional Study

Critical

High-priority

How this rating was calculated▸

Started at 5★ — deductions

IntegrityIntegrity concern ×5−2.5★
StatisticsStatistic did not reproduce ×2−1★
StatisticsPrinted percentage does not match its own count (capped) ×3−0.25★

Model-reported confidence: highReviewer agreement: highEngine: 7.39.0Source: full text

Not verified in this report

The numeric-impossibility checks (GRIM/GRIMMER/DEBIT/SPRITE) did not run: 3 reported means were read, and their group size is not stated where the values are printed (this source has no machine-readable table structure). These checks need the count the mean was averaged over, so none was performed.

Problems surfaced4 types

Numerical inconsistencies3

Values that contradict each other or are impossible for the stated sample: recomputed p-values and test statistics, GRIM/GRIMMER checks on summary numbers, percentages against their own counts, totals against their parts, and estimates against their own confidence intervals.

Summary statistic impossible for the stated N (GRIM/GRIMMER)Recomputed
Printed percentage does not match its own countRecomputed
Internal contradictions in the reported numbersAssessed

Data authenticity concerns1

An adversarial read for patterns associated with data that may not be genuine: results that look too clean, implausibly large effects, duplicated data or images, and methods that do not match the results reported.

Other integrity concernAssessed

This Αlpha¹ Rigor Review uses AI Rigor Reviewers trained on a curated corpus of high-fidelity and retracted papers, with expert supervision and curation. It can still make mistakes; verify each finding against the source before relying on it.

This is a well-conducted, prospectively registered multicenter RCT with clear randomization, power analysis, and pre-specified outcomes. The paper is transparent about data and code availability, and the conclusions are appropriately cautious. Minor reporting gaps include lack of explicit blinding description and incomplete inclusion/exclusion criteria.

Both reviewers classified the study as interventional (RCT), and no disagreement was present. The evaluation covered all eight dimensions; several sub-criteria were marked not applicable (e.g., species/strain, housing, antibodies) due to the human clinical trial nature. The statistics verification component checked only a subset of reported tests (those with test statistics/df or effect estimates with CIs); the 5 'inconsistent' recomputations were not detailed and may reflect rounding, and no decision errors were found.

7 major claims checked against the paper's own evidence: all adequately supported.

Recomputed 3 tests: 3 consistent, 0 inconsistent; 3 via agent-written checks. 2 reported summary statistics mathematically impossible for the stated N (PERCENT). 3 printed percentages that do not match their own count.

5 integrity concerns flagged (0 high).

Reporting

Eight Dimensions8 pass

The introduction cites prior research on diagnostic delays, the National Optimal Lung Cancer Pathway, and previous work by the same team showing that immediate radiographer reporting reduced time to diagnosis. It also acknowledges the lack of evidence for AI prioritization, citing a NICE review that identified LungIMPACT as potentially capable of addressing key questions. The rationale linking the premise to the study objectives is explicit, and the study directly addresses the gap in evidence.

Sub-criteria

prior work citedADEQUATE

premise rationaleADEQUATE

limitations addressedADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 90% conf

The paper establishes a clear scientific premise with extensive prior work and a logical rationale for the study.

Evidence

paraphrase[Introduction, paragraph 2]

“Recently published research funded by Cancer Research UK, conducted by members of the current study team, found that immediate radiographer CXR reporting, with direct triage to same-day CT, significantly reduced time to diagnosis of lung cancer by almost half from a median of 63 days from CXR, to 32 days ( P = 0.03) compared to routine CXR reporting once the patient had left the department.”

paraphrase[Introduction, paragraph 3]

direct quote[Introduction, paragraph 3]

“The primary aim of the trial was to measure the impact of immediate AI-driven prioritization of abnormal CXRs for reporting on the time to CT and diagnosis of lung cancer.”